PIK3CD and autoimmune disease: Unlike the ubiquitous p110α and p110β PI3K catalytic isoforms, p110δ is predominantly expressed in cells of hematopoietic lineage and sensory neurons [54,55,56], and p110δ isoform-specific inhibitors are currently being explored in the clinic for B-cell malignancies and some autoimmune diseases [57].